Waters Corporation

Waters Corporation is a United States-based manufacturer of analytical instruments, consumables, software, and laboratory systems. Founded in 1958 by James Logan Waters, the company developed from a small Massachusetts laboratory-equipment venture into a major supplier to pharmaceutical, biotechnology, chemical, food, environmental, academic, and materials-science laboratories. Its principal technologies include high-performance liquid chromatography, ultra-performance liquid chromatography, mass spectrometry, sample preparation, laboratory informatics, and rheometry. The company's early development was closely connected with the emergence of modern separation science. After licensing a Dow Chemical polymer-analysis method in the early 1960s, Waters produced gel-permeation chromatography equipment and subsequently expanded into liquid chromatography. Its 1967 ALC 100 was an early Waters liquid-chromatography system, while the M6000 pump helped establish the company's reputation for accurate high-pressure solvent delivery. By the late 1970s, Waters had become one of the leading suppliers in liquid chromatography. Waters was acquired by Millipore in 1980 and operated for more than a decade as the Waters Chromatography Division of Millipore. Growth weakened during the 1980s and early 1990s, partly because of economic downturns, organizational disruption, and the difficulty of realizing the anticipated benefits of the combination. In 1994, a management-led investor group bought the business, restoring its independence and establishing a renewed growth strategy under Douglas A. Berthiaume. Waters returned to the public markets in 1995. The company broadened its capabilities through acquisitions and product development. The 1996 purchase of TA Instruments added materials-characterization and rheology capabilities, and the 1997 acquisition of Micromass brought mass spectrometry into the portfolio. In 2004, the ACQUITY UPLC platform advanced liquid chromatography through smaller-particle columns, faster separations, and improved resolution and sensitivity. Other important product families include Alliance HPLC systems, Xevo and SYNAPT mass spectrometers, Waters chromatography columns, Oasis sample-preparation products, Empower chromatography data software, MassLynx mass-spectrometry software, and NuGenesis laboratory-management systems. Waters also serves regulated industries where analytical results support drug development, manufacturing release, quality control, food-safety testing, environmental analysis, and research. Its business combines capital equipment with recurring revenue from columns, consumables, service, software, and application support. Manufacturing and operations span multiple United States sites and international facilities, including locations in Europe, China, India, and Singapore. Its principal competitors include Agilent Technologies, Thermo Fisher Scientific, Revvity, and Danaher. Recent expansion has emphasized laboratory automation, food analysis, advanced characterization, and biopharmaceutical research. Waters acquired Andrew Alliance in 2020 to add laboratory-automation software and robotics capabilities, and acquired Wyatt Technology in 2023, strengthening its position in light-scattering, macromolecular characterization, and biophysical analysis. The company announced a proposed combination with Becton Dickinson's biosciences and diagnostics business in 2025; the supplied reference material states that the transaction was completed in February 2026, although the legal and corporate consequences of that reported completion should be independently verified.

James Logan Waters founded Waters Associates in 1958 in Framingham, Massachusetts. The company's earliest work covered a diverse set of measurement and detection devices, including a boiler-feedwater flame photometer, hydrometers, refractometers, and a nerve-gas detector. Its later specialization emerged from work with Dow Chemical, which had developed a polymer-analysis approach using gel columns. Waters obtained an exclusive license to the relevant technology and used it as a foundation for commercial gel-permeation chromatography instruments. External financing began in 1962, when Hardie Sheppard provided the company with $150,000. In 1963, Waters built its first five gel-permeation chromatography instruments, selling units to Dow Chemical, BFGoodrich, and Esso. Dow subsequently invested in the company, while a 1965 symposium helped increase awareness among scientists of the practical uses of Waters equipment. Dow later converted royalty interests into equity. Millipore became involved in 1969 when its chairman, Dimitri D'Arbeloff, joined the Waters board and a Millipore venture subsidiary invested in the company. Waters introduced the ALC 100 in 1967, an early liquid-chromatography system combining a pump, syringe injector, differential refractive-index detection, and ultraviolet detection. In 1972, the company assisted Helmut Hamberger with a difficult separation related to vitamin B12 synthesis, demonstrating the practical importance of its chromatographic technology. The company moved its headquarters to Milford in 1973 after appointing Frank Zenie as president. It also developed the M6000 pump, a high-pressure, high-accuracy pumping platform that became an important technical and commercial milestone. Waters became publicly traded in 1973. By the end of the 1970s, Waters had achieved a strong position in liquid chromatography, with a large installed customer base and substantial market share. In May 1980, Millipore acquired Waters for $167 million, and the business became the Waters Chromatography Division of Millipore. The combination did not deliver the expected commercial benefits. Competitive pressures, recessions, management losses, and a lack of strategic focus contributed to a prolonged period of weak growth. Among the disruptions were the death of D'Arbeloff and the deaths of senior technical and operating executives in a helicopter crash. A management-led investor group reacquired the business in 1994 for $360 million. The independent company introduced Symmetry HPLC columns that year and pursued a more focused growth plan under chief executive Douglas A. Berthiaume. Waters returned to the public markets through a 1995 initial public offering. In 1996, its acquisition of TA Instruments added rheology and materials-characterization products. In 1997, the purchase of Micromass for $176 million moved Waters into mass spectrometry and created the basis for later Xevo and SYNAPT platforms. The 2004 launch of ACQUITY UPLC was a major product turning point. By using advanced small-particle chromatography and a system designed for high-pressure operation, the platform sought to improve separation speed, resolution, and sensitivity compared with conventional HPLC workflows. Waters later expanded into food-safety and rapid-detection applications through the 2006 acquisition of Vicam. Its broader portfolio came to include chromatography systems and columns, mass spectrometers, sample preparation, software, laboratory-management tools, and rheometry. In 2020, Waters acquired Andrew Alliance, extending its reach into laboratory robotics and automation, and appointed Udit Batra as president and chief executive officer. In 2023, it acquired Wyatt Technology, strengthening its offerings for macromolecular and biophysical characterization. The company announced a proposed combination with Becton Dickinson's biosciences and diagnostics business in 2025. The supplied reference material further reports completion in February 2026 and describes related shareholder litigation concerning proxy disclosures; these later developments require confirmation through primary corporate and regulatory sources.

1. 2025Proposed Becton Dickinson combination

   Waters announced a proposed merger with Becton Dickinson's biosciences and diagnostics business.

   Source
2. 2023Wyatt Technology acquisition

   Waters expanded into advanced macromolecular and biophysical characterization.

   Source
3. 2020Andrew Alliance acquisition

   Waters added laboratory-automation software and robotics capabilities.

   Source
4. 2006Vicam acquisition

   The acquisition expanded Waters' food-safety and rapid-detection activities.

   Source
5. 2004ACQUITY UPLC launch

   Waters introduced ACQUITY UPLC, a faster, higher-resolution liquid-chromatography platform.

   Source
6. 1997Micromass acquisition

   Waters entered the mass-spectrometry market through the acquisition of Micromass.

   Source
7. 1996TA Instruments acquisition

   The acquisition added rheology and materials-characterization capabilities.

   Source
8. 1995Return to public markets

   Waters completed a new initial public offering.

   Source
9. 1994Management-led buyout

   An investor group led by management reacquired Waters and restored its independence.

   Source
10. 1980Acquisition by Millipore

    Millipore acquired Waters, which operated as its Waters Chromatography Division.

    Source
11. 1973Milford headquarters and public listing

    Waters moved to Milford, Massachusetts, and became publicly traded.

    Source
12. 1967ALC 100 liquid-chromatography system

    The company introduced the ALC 100, an early Waters liquid-chromatography platform.

    Source
13. 1963First gel-permeation chromatography instruments

    Waters produced its first five gel-permeation chromatography instruments for industrial customers.

    Source
14. 1958Waters Associates is founded

    James Logan Waters established Waters Associates in Framingham, Massachusetts.

    Source

A premium, application-focused provider of analytical measurement platforms for regulated laboratories and advanced life-science, food, chemical, and materials research.

• ACQUITY UPLC and UPC2 systemsLiquid chromatography2004

  ACQUITY systems are Waters' principal high-performance separation platforms. UPLC systems use high-pressure operation and small-particle columns to deliver fast analyses, high chromatographic resolution, and sensitivity for pharmaceutical, biochemical, food, and research applications. The related UPC2 family extends the platform concept to separations using compressed-fluid mobile phases.

• Alliance HPLC systemsLiquid chromatography1996

  Alliance systems are conventional HPLC platforms designed for routine, reproducible laboratory analysis. They are used in quality-control and regulated workflows where standardized methods, dependable operation, and compatibility with Waters columns and software are important.

• Xevo mass spectrometersMass spectrometry

  Xevo instruments combine liquid chromatography with mass spectrometric detection for quantitative and qualitative analysis. The family supports applications such as pharmaceutical development, bioanalysis, metabolomics, food testing, and environmental measurement, with configurations spanning routine quantitative work and more demanding high-resolution workflows.

• SYNAPT MS and HDMS systemsMass spectrometry

  SYNAPT systems are high-end mass-spectrometry platforms associated with ion mobility, high-resolution analysis, and structural characterization. They are intended for complex biological and chemical samples, including proteins, metabolites, polymers, and other molecules requiring separation and characterization beyond basic mass measurement.

• Chromatography columnsConsumables

  Waters supplies columns and related separation consumables under brands including Symmetry, XBridge, XTerra, and Zodiac. These products provide stationary phases and formats for reversed-phase, size-exclusion, and other chromatographic methods and are an important recurring component of the company's laboratory business.

• Oasis sample-preparation productsSample preparation

  Oasis products support sample cleanup and concentration before chromatographic or mass-spectrometric analysis. They are used to remove interfering compounds, improve analytical robustness, and prepare complex biological, food, pharmaceutical, and environmental samples.

• Empower softwareLaboratory software

  Empower is Waters' chromatography data and laboratory-control software environment. It supports instrument control, acquisition, processing, reporting, and data management, particularly in laboratories requiring repeatable methods and documentation for quality and regulatory purposes.

• MassLynx softwareLaboratory software

  MassLynx is software for operating Waters mass spectrometers and managing mass-spectrometry acquisition and analysis workflows. It supports instrument control, data processing, qualitative interpretation, and quantitative applications.

• NuGenesis laboratory-management systemLaboratory informatics

  NuGenesis provides laboratory-information and content-management functions intended to connect analytical data, documents, methods, and workflows. It is designed for organizations that need broader governance and traceability across scientific and regulated laboratory operations.

• TA Instruments rheology and materials-analysis systemsMaterials characterization

  The TA Instruments business supplies rheometers and related materials-characterization equipment. These systems measure mechanical, thermal, and flow behavior of polymers, formulations, pharmaceuticals, and other materials, complementing Waters' separation and molecular-analysis technologies.

• 2025Propose combination with Becton Dickinson biosciences and diagnostics businessM&A

  Waters sought to expand its position in life-science tools and diagnostics through a large-scale corporate combination.

  What changed. The company announced a merger agreement subject to shareholder and other required approvals.

  Aftermath. The supplied reference material reports completion in February 2026, alongside shareholder litigation concerning disclosure adequacy; both developments require primary-source confirmation.

  Source
• 2023Acquire Wyatt TechnologyM&A

  Waters aimed to expand its presence in advanced characterization of proteins, polymers, nanoparticles, and other complex molecules.

  What changed. Waters acquired Wyatt Technology for cash.

  Aftermath. Wyatt's light-scattering and macromolecular-characterization technologies strengthened Waters' biophysical-analysis offering.

  Acquisition price. $1.36 billion (May 2023)

  Source
• 2020Acquire Andrew AllianceM&A

  Laboratories were increasingly adopting automation and connected robotic workflows.

  What changed. Waters acquired Andrew Alliance, a provider of laboratory-automation software and robotics.

  Aftermath. The transaction broadened Waters' capabilities beyond analytical measurement into automated laboratory operations.

  Source
• 2004Launch ACQUITY UPLCProduct launch

  Laboratories increasingly sought greater analytical speed, resolution, and sensitivity than conventional HPLC could provide.

  What changed. Waters introduced the ACQUITY UPLC platform using high-pressure, small-particle chromatography technology.

  Aftermath. The platform became one of Waters' most important product families and reinforced its position in high-performance liquid chromatography.

  Source
• 1997Enter mass spectrometry through MicromassM&A

  Waters sought to broaden beyond chromatography and participate in a complementary analytical-technology market.

  What changed. The company acquired Micromass.

  Aftermath. Mass spectrometry became a core part of Waters' portfolio and supported later integrated LC-MS platforms.

  Acquisition price. $176 million (1997)

  Source
• 1980Join MilliporeM&A

  Waters was a leading chromatography business but faced increasing competition and later encountered economic and organizational difficulties.

  What changed. Millipore acquired the company and operated it as the Waters Chromatography Division.

  Aftermath. Expected synergies did not fully materialize, and growth weakened until the management-led buyout in 1994.

  Acquisition price. $167 million (May 1980)

  Source
• 1961License Dow Chemical polymer-analysis technologyStrategy

  Dow Chemical had developed a polymer-analysis method using gel columns, creating an opportunity for Waters to commercialize separation instrumentation.

  What changed. Waters negotiated an exclusive license in exchange for an upfront payment and royalties.

  Aftermath. The technology helped move the company toward gel-permeation chromatography and became an early foundation for its analytical-instrument business.

  Source

• 2025Litigation concerning proposed Becton Dickinson transaction disclosuresControversy

  The supplied reference material reports shareholder suits alleging that Waters' proxy materials omitted important details about its proposed combination with Becton Dickinson's biosciences and diagnostics business. The allegations, the scale of claimed damages, and the litigation outcome require verification from court records and company filings.

  Source

• 2026Waters reports completion of Becton Dickinson business merger

  The supplied reference material states that Waters announced completion of the merger on February 9, 2026. This reported event should be verified against an official filing or company announcement.

  M&A
  Source
• 2025Waters announces proposed combination with Becton Dickinson biosciences and diagnostics operations

  Waters announced an agreement to combine with Becton Dickinson's biosciences and diagnostics business, subject to required approvals.

  M&A
  Source
• 2023Waters acquires Wyatt Technology

  The acquisition expanded Waters' capabilities in light scattering, macromolecular characterization, and biophysical analysis.

  M&A
  Source
• 2020Waters acquires Andrew Alliance

  Waters acquired Andrew Alliance, adding laboratory-automation software and robotics capabilities to its analytical-instrument portfolio.

  M&A
  Source
• 2020Udit Batra becomes Waters president and chief executive officer

  Waters appointed Udit Batra as president and chief executive officer.

  Leadership change
  Source

1. Waters Corporation
2. Waters Corporation official website